 Chertow et al, JASN 16: 3365-3370, 2005 Chertow et al, JASN 16: 3365-3370, 2005 
R (I) I (II) F (III)
Increased SCr x1.5 OR > 0.3 mg/dL UO < .3ml/kg/h x 24 hr or Anuria x 12 hrs UO < .5ml/kg/h x 12 hr UO < .5ml/kg/h x 6 hr Increased SCr x2
Increase SCr x3 or SCr 4mg/dl (Acute rise of 0.5 mg/dl)
High Sensitivity

High Specificity
RRT Started
Modifications proposed by AKIN Amsterdam, 2005 I (II)
Criterion must be reached within 48hr AKIN Criteria (Rifle V2.0) KDOQI Commentary AJKD 2013 KDIGO AKI Guidelines: Definition of AKI Problems with Serum Creatinine  Creatinine is influenced by age, muscle mass, gender, and ethnicity  Creatinine does not reflect the presence or absence of structural injury and thus provides no guidance on AKI etiology or the likelihood of response to various targeted therapies  The rise is serum creatinine is delayed by 2-3 days after the injury has occurred  Fluid therapy may dilute serum creatinine and therefore delay diagnosis  Inter-laboratory variation in measuring creatinine, and bilirubin and other compounds interfere with the colorimetric modified Jaffe assay hence affect serum creatinine levels 
Serum Creatinine and GFR in AKI
 Cardiac   venous return   cardiac output   CVP, PCWP & SVR  Pulmonary   intrathoracic & airway pressures   PaO2   PaCO2  GI   splanchnic perfusion  CNS   intracranial pressure,   perfusion pressure  Renal   renal perfusion   GFR  
